Development and Characterization of Broadly Cross-reactive Monoclonal Antibodies Against All Known Ebolavirus Species

Humberto Hernandez, Caleb Marceau, Hailey Halliday, Julie Callison, Viktoriya Borisevich, Olivier Escaffre, Jeffrey Creech, Heinz Feldmann, Barry Rockx

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

As of 25 March 2015, the largest recorded outbreak of Ebola virus infection is ongoing, with almost 25 000 cases and >10 000 deaths. There are 5 genetically and antigenically distinct species within the genus Ebolavirus. Limited cross-reactivity and protection is observed between these 5 Ebolavirus species, which complicates vaccine development. However, on the basis of sequence homology between the 5 Ebolavirus species, we hypothesize that conserved epitopes are present on the viral glycoprotein (GP), which can be targeted by antibodies. In the current study, a panel of mouse monoclonal antibodies was isolated and characterized using an enzyme-linked immunosorbent assay (ELISA) to determine cross-reactivity, avidity, and competition for epitope binding; Western blot analysis was also performed. Four monoclonal antibodies were identified by ELISA as cross-reacting with the GPs of all 5 Ebolavirus species. The identification of cross-reactive antibodies that bind the GPs of all known Ebolavirus species will give us important insight into the presence of conserved epitopes on the viral GP. These data will be crucial for the development of novel therapeutics and diagnostic assays.

Original languageEnglish (US)
Pages (from-to)S410-S413
JournalJournal of Infectious Diseases
Volume212
DOIs
StatePublished - Oct 1 2015

Fingerprint

Ebolavirus
Monoclonal Antibodies
Epitopes
Glycoproteins
Ebola Hemorrhagic Fever
Enzyme-Linked Immunosorbent Assay
Cross Protection
Antibodies
Sequence Homology
Disease Outbreaks
Vaccines
Western Blotting

Keywords

  • antibody
  • cross-reactive
  • Ebolavirus

ASJC Scopus subject areas

  • Infectious Diseases
  • Immunology and Allergy
  • Medicine(all)

Cite this

Hernandez, H., Marceau, C., Halliday, H., Callison, J., Borisevich, V., Escaffre, O., ... Rockx, B. (2015). Development and Characterization of Broadly Cross-reactive Monoclonal Antibodies Against All Known Ebolavirus Species. Journal of Infectious Diseases, 212, S410-S413. https://doi.org/10.1093/infdis/jiv209

Development and Characterization of Broadly Cross-reactive Monoclonal Antibodies Against All Known Ebolavirus Species. / Hernandez, Humberto; Marceau, Caleb; Halliday, Hailey; Callison, Julie; Borisevich, Viktoriya; Escaffre, Olivier; Creech, Jeffrey; Feldmann, Heinz; Rockx, Barry.

In: Journal of Infectious Diseases, Vol. 212, 01.10.2015, p. S410-S413.

Research output: Contribution to journalArticle

Hernandez, H, Marceau, C, Halliday, H, Callison, J, Borisevich, V, Escaffre, O, Creech, J, Feldmann, H & Rockx, B 2015, 'Development and Characterization of Broadly Cross-reactive Monoclonal Antibodies Against All Known Ebolavirus Species', Journal of Infectious Diseases, vol. 212, pp. S410-S413. https://doi.org/10.1093/infdis/jiv209
Hernandez, Humberto ; Marceau, Caleb ; Halliday, Hailey ; Callison, Julie ; Borisevich, Viktoriya ; Escaffre, Olivier ; Creech, Jeffrey ; Feldmann, Heinz ; Rockx, Barry. / Development and Characterization of Broadly Cross-reactive Monoclonal Antibodies Against All Known Ebolavirus Species. In: Journal of Infectious Diseases. 2015 ; Vol. 212. pp. S410-S413.
@article{5058dc9a2e0b4f8ebfbb1c2d057b4d31,
title = "Development and Characterization of Broadly Cross-reactive Monoclonal Antibodies Against All Known Ebolavirus Species",
abstract = "As of 25 March 2015, the largest recorded outbreak of Ebola virus infection is ongoing, with almost 25 000 cases and >10 000 deaths. There are 5 genetically and antigenically distinct species within the genus Ebolavirus. Limited cross-reactivity and protection is observed between these 5 Ebolavirus species, which complicates vaccine development. However, on the basis of sequence homology between the 5 Ebolavirus species, we hypothesize that conserved epitopes are present on the viral glycoprotein (GP), which can be targeted by antibodies. In the current study, a panel of mouse monoclonal antibodies was isolated and characterized using an enzyme-linked immunosorbent assay (ELISA) to determine cross-reactivity, avidity, and competition for epitope binding; Western blot analysis was also performed. Four monoclonal antibodies were identified by ELISA as cross-reacting with the GPs of all 5 Ebolavirus species. The identification of cross-reactive antibodies that bind the GPs of all known Ebolavirus species will give us important insight into the presence of conserved epitopes on the viral GP. These data will be crucial for the development of novel therapeutics and diagnostic assays.",
keywords = "antibody, cross-reactive, Ebolavirus",
author = "Humberto Hernandez and Caleb Marceau and Hailey Halliday and Julie Callison and Viktoriya Borisevich and Olivier Escaffre and Jeffrey Creech and Heinz Feldmann and Barry Rockx",
year = "2015",
month = "10",
day = "1",
doi = "10.1093/infdis/jiv209",
language = "English (US)",
volume = "212",
pages = "S410--S413",
journal = "Journal of Infectious Diseases",
issn = "0022-1899",
publisher = "Oxford University Press",

}

TY - JOUR

T1 - Development and Characterization of Broadly Cross-reactive Monoclonal Antibodies Against All Known Ebolavirus Species

AU - Hernandez, Humberto

AU - Marceau, Caleb

AU - Halliday, Hailey

AU - Callison, Julie

AU - Borisevich, Viktoriya

AU - Escaffre, Olivier

AU - Creech, Jeffrey

AU - Feldmann, Heinz

AU - Rockx, Barry

PY - 2015/10/1

Y1 - 2015/10/1

N2 - As of 25 March 2015, the largest recorded outbreak of Ebola virus infection is ongoing, with almost 25 000 cases and >10 000 deaths. There are 5 genetically and antigenically distinct species within the genus Ebolavirus. Limited cross-reactivity and protection is observed between these 5 Ebolavirus species, which complicates vaccine development. However, on the basis of sequence homology between the 5 Ebolavirus species, we hypothesize that conserved epitopes are present on the viral glycoprotein (GP), which can be targeted by antibodies. In the current study, a panel of mouse monoclonal antibodies was isolated and characterized using an enzyme-linked immunosorbent assay (ELISA) to determine cross-reactivity, avidity, and competition for epitope binding; Western blot analysis was also performed. Four monoclonal antibodies were identified by ELISA as cross-reacting with the GPs of all 5 Ebolavirus species. The identification of cross-reactive antibodies that bind the GPs of all known Ebolavirus species will give us important insight into the presence of conserved epitopes on the viral GP. These data will be crucial for the development of novel therapeutics and diagnostic assays.

AB - As of 25 March 2015, the largest recorded outbreak of Ebola virus infection is ongoing, with almost 25 000 cases and >10 000 deaths. There are 5 genetically and antigenically distinct species within the genus Ebolavirus. Limited cross-reactivity and protection is observed between these 5 Ebolavirus species, which complicates vaccine development. However, on the basis of sequence homology between the 5 Ebolavirus species, we hypothesize that conserved epitopes are present on the viral glycoprotein (GP), which can be targeted by antibodies. In the current study, a panel of mouse monoclonal antibodies was isolated and characterized using an enzyme-linked immunosorbent assay (ELISA) to determine cross-reactivity, avidity, and competition for epitope binding; Western blot analysis was also performed. Four monoclonal antibodies were identified by ELISA as cross-reacting with the GPs of all 5 Ebolavirus species. The identification of cross-reactive antibodies that bind the GPs of all known Ebolavirus species will give us important insight into the presence of conserved epitopes on the viral GP. These data will be crucial for the development of novel therapeutics and diagnostic assays.

KW - antibody

KW - cross-reactive

KW - Ebolavirus

UR - http://www.scopus.com/inward/record.url?scp=84943242445&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84943242445&partnerID=8YFLogxK

U2 - 10.1093/infdis/jiv209

DO - 10.1093/infdis/jiv209

M3 - Article

C2 - 25999057

AN - SCOPUS:84943242445

VL - 212

SP - S410-S413

JO - Journal of Infectious Diseases

JF - Journal of Infectious Diseases

SN - 0022-1899

ER -